Across TCGA pan-cancer cohorts, MTND4P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTND4P3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MTND4P3 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND4P3 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC and THCA are the cancer types where MTND4P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND4P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.011	.019	3	view →
THCA	All	All	−0.025	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MTND4P3 RNA expression & survival · all MTND4P3 data types